Physician

Adam Z Matysiak, RPA-C

According to 2025 Medicare claims, Adam Matysiak, RPA-C (NPI: 1073684486) practices physician assistant in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is SUMMIT MEDICAL GROUP PA (NPI: 1942254347; TIN: 223487984) and primary practice location at 07652-5101. Matysiak is affiliated with the Summit Health ACO (ACO ID: A5049), participating under the MSSP model.

Matysiak's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 370 traditional Medicare patients, billed 708 HCPCS/CPT codes, and received $35,986 in Medicare payments. The top billing code was 87428 (Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza). Part D data shows 196 prescription claims across 169 beneficiaries totaling $4,538 in drug costs, led by Albuterol Sulfate Hfa (Albuterol Sulfate). Open Payments data shows 1 records totaling $128. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $223 to $4,538. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$31K$61K2020 Medicare payment: $5,225 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $13,236 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $61,364 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $36,216 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $35,986 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20205874$5,225
2021118225$13,236
20224971,107$61,364
2023365735$36,216
2024370708$35,986

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$3.6K$7.2K2020 Drug cost: $223 (USD; Tot_Drug_Cst)2021 Drug cost: $511 (USD; Tot_Drug_Cst)2022 Drug cost: $4,261 (USD; Tot_Drug_Cst)2023 Drug cost: $7,224 (USD; Tot_Drug_Cst)2024 Drug cost: $4,538 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20201922$223
20211315$511
2022128147$4,261
2023152185$7,224
2024169196$4,538

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
87428Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza8686$68
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more9898$62
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more223232$60
87426Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus3232$35
81003Automated urinalysis test3535$2

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Albuterol Sulfate HfaAlbuterol Sulfate12268$213
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst21124$188
CephalexinCephalexin17106$67
PrednisonePrednisone23156$44

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$128Janssen Pharmaceuticals, Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam Z. Matysiak, RPA-C?

Tedicare shows public-source Medicare data for Adam Z. Matysiak, RPA-C (NPI 1073684486), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Z. Matysiak, RPA-C have ACO affiliation data?

Adam Z. Matysiak, RPA-C is shown with ACO affiliation data for Summit Health ACO (MSSP, ACO ID A5049).

What billing organization is linked to Adam Z. Matysiak, RPA-C?

Adam Z. Matysiak, RPA-C is linked to SUMMIT MEDICAL GROUP PA (billing NPI 1942254347) in the available physician profile data.

Does Adam Z. Matysiak, RPA-C have Open Payments data?

Adam Z. Matysiak, RPA-C has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.